SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-264855
Filing Date
2020-10-06
Accepted
2020-10-06 17:26:03
Documents
14
Period of Report
2020-10-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d32692d8k.htm   iXBRL 8-K 25470
2 EX-99.1 d32692dex991.htm EX-99.1 10264
6 GRAPHIC g32692g1007014232367.jpg GRAPHIC 4937
  Complete submission text file 0001193125-20-264855.txt   173369

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20201006.xsd EX-101.SCH 3087
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20201006_lab.xml EX-101.LAB 18907
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20201006_pre.xml EX-101.PRE 11874
7 EXTRACTED XBRL INSTANCE DOCUMENT d32692d8k_htm.xml XML 3484
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 201227596
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences